This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
Ligand Pharmaceuticals Inc
LGND : NASDAQ : Health Care
$52.32 | %
Today's Range: 51.91 - 53.11
Avg. Daily Volume: 363,200
12/19/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
LGND LIGAND PHARMACEUTICAL INC 53.89 1071.66 168.41 56.28 17.55
NLNK NEWLINK GENETICS CORP 35.42 990.34 n/m 3.64 231.60
EBS EMERGENT BIOSOLUTIONS INC 26.37 990.25 54.94 400.27 29.43
CMRX CHIMERIX INC 34.62 1262.76 n/m 3.76 7.79
ARIA ARIAD PHARMACEUTICALS INC 6.47 1211.26 n/m 46.93 25.87
PDLI PDL BIOPHARMA INC 7.49 1203.30 3.82 465.73 11.19
KPTI KARYOPHARM THERAPEUTICS INC 33.50 1095.48 n/m 0.24 n/a
MACK MERRIMACK PHARMACEUTICALS 10.22 1082.13 n/m 76.67 41.58
GHDX GENOMIC HEALTH INC 32.66 1036.04 n/m 275.40 8.76
AMAG AMAG PHARMACEUTICALS INC 40.83 1033.20 n/m 92.84 15.63
HALO HALOZYME THERAPEUTICS INC 8.15 1021.90 n/m 57.46 -10.36
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

LGND Ind Avg S&P 500
168.41 66.62 19.74

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs